<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Health Serv Res</journal-id><journal-id journal-id-type="iso-abbrev">BMC Health Serv Res</journal-id><journal-id journal-id-type="pmc-domain-id">34</journal-id><journal-id journal-id-type="pmc-domain">bmchsr</journal-id><journal-title-group><journal-title>BMC Health Services Research</journal-title></journal-title-group><issn pub-type="epub">1472-6963</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10464437</article-id><article-id pub-id-type="pmcid-ver">PMC10464437.1</article-id><article-id pub-id-type="pmcaid">10464437</article-id><article-id pub-id-type="pmcaiid">10464437</article-id><article-id pub-id-type="pmid">37608371</article-id><article-id pub-id-type="doi">10.1186/s12913-023-09854-1</article-id><article-id pub-id-type="publisher-id">9854</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Predictors of frequent emergency department visits among hospitalized cancer patients: a comparative cohort study using integrated clinical and administrative data to improve care delivery</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Kurteva</surname><given-names initials="S">Siyana</given-names></name><address><email>siyana.kurteva@mail.mcgill.ca</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Tamblyn</surname><given-names initials="R">Robyn</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Meguerditchian</surname><given-names initials="AN">Ari N.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff7">7</xref><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01pxwe438</institution-id><institution-id institution-id-type="GRID">grid.14709.3b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8649</institution-id><institution>Department of Epidemiology and Biostatistics, </institution><institution>McGill University, </institution></institution-wrap>Montreal, Canada </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01pxwe438</institution-id><institution-id institution-id-type="GRID">grid.14709.3b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8649</institution-id><institution>Clinical and Health Informatics Research Group, </institution><institution>McGill University, </institution></institution-wrap>Montreal, Canada </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02efksf92</institution-id><institution-id institution-id-type="GRID">grid.455208.e</institution-id><institution>Department of Science, </institution><institution>Aetion, Inc, </institution></institution-wrap>New York, USA </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01pxwe438</institution-id><institution-id institution-id-type="GRID">grid.14709.3b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8649</institution-id><institution>Clinical &amp; Health Informatics Research Group, Department of Medicine, </institution><institution>McGill University, </institution></institution-wrap>2001 McGill College Avenue, Suite 1200, H3A 1G1 Montreal, Canada </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01pxwe438</institution-id><institution-id institution-id-type="GRID">grid.14709.3b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8649</institution-id><institution>Department of Medicine, </institution><institution>McGill University Health Center, </institution></institution-wrap>Montreal, Canada </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.63984.30</institution-id><institution-id institution-id-type="ISNI">0000 0000 9064 4811</institution-id><institution>McGill University Health Centre, </institution></institution-wrap>Montreal, Canada </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01pxwe438</institution-id><institution-id institution-id-type="GRID">grid.14709.3b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8649</institution-id><institution>Department of Surgery, </institution><institution>McGill University Health Center, </institution></institution-wrap>Montreal, Canada </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04cpxjv19</institution-id><institution-id institution-id-type="GRID">grid.63984.30</institution-id><institution-id institution-id-type="ISNI">0000 0000 9064 4811</institution-id><institution>Center for Outcomes Research and Evaluation, </institution><institution>McGill University Health Centre, </institution></institution-wrap>Montreal, Canada </aff><aff id="Aff9"><label>9</label>St. Mary&#8217;s Research Centre, Montreal, Canada </aff></contrib-group><pub-date pub-type="epub"><day>22</day><month>8</month><year>2023</year></pub-date><pub-date pub-type="collection"><year>2023</year></pub-date><volume>23</volume><issue-id pub-id-type="pmc-issue-id">424977</issue-id><elocation-id>887</elocation-id><history><date date-type="received"><day>18</day><month>1</month><year>2023</year></date><date date-type="accepted"><day>27</day><month>7</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>22</day><month>08</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>30</day><month>08</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-02-12 01:25:11.223"><day>12</day><month>02</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2023</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12913_2023_Article_9854.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Frequent emergency department (FED) visits by cancer patients represent a significant burden to the health system. This study identified determinants of FED in recently hospitalized cancer patients, with a particular focus on opioid use.</p></sec><sec><title>Methods</title><p id="Par2">A prospective cohort discharged from surgical/medical units of the McGill University Health Centre was assembled. The outcome was FED use (&#8805;&#8201;4 ED visits) within one year of discharge. Data retrieved from the universal health insurance system was analyzed using Cox Proportional Hazards (PH) model, adopting the Lunn-McNeil approach for competing risk of death.</p></sec><sec><title>Results</title><p id="Par3">Of 1253 patients, 14.5% became FED users. FED use was associated with chemotherapy one-year pre-admission (adjusted hazard ratio (aHR) 2.60, 95% CI: 1.80&#8211;3.70), &#8805;1 ED visit in the previous year (aHR: 1.80, 95% CI 1.20&#8211;2.80), &#8805;15 pre-admission ambulatory visits (aHR 1.54, 95% CI 1.06&#8211;2.34), previous opioid and benzodiazepine use (aHR: 1.40, 95% CI: 1.10&#8211;1.90 and aHR: 1.70, 95% CI: 1.10&#8211;2.40), Charlson Comorbidity Index &#8805; 3 (aHR: 2.0, 95% CI: 1.2&#8211;3.4), diabetes (aHR: 1.60, 95% CI: 1.10&#8211;2.20), heart disease (aHR: 1.50, 95% CI: 1.10&#8211;2.20) and lung cancer (aHR: 1.70, 95% CI: 1.10&#8211;2.40). Surgery (cardiac (aHR: 0.33, 95% CI: 0.16&#8211;0.66), gastrointestinal (aHR: 0.34, 95% CI: 0.14&#8211;0.82) and thoracic (aHR: 0.45, 95% CI: 0.30&#8211;0.67) led to a decreased risk of FED use.</p></sec><sec><title>Conclusions</title><p id="Par4">Cancer patients with higher co-morbidity, frequent use of the healthcare system, and opioid use were at increased risk of FED use. High-risk patients should be flagged for preventive intervention.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s12913-023-09854-1.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Emergency department visits</kwd><kwd>Cancer</kwd><kwd>Cohort study</kwd><kwd>Frequent users</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2023</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par14">Unplanned acute healthcare use after hospitalization remains an important health system challenge. Emergency department (ED) care account for a large proportion of healthcare system spending [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. While some ED visits may represent the only option for patients when they experience acute symptoms, the occurrence of a significant number of ED visits, which may lead to negative patient experiences, is medication-related and preventable [<xref ref-type="bibr" rid="CR3">3</xref>&#8211;<xref ref-type="bibr" rid="CR8">8</xref>]. The impact of ED visits is even more pronounced in cancer patients, as emergency use is associated with treatment errors, delays and adverse outcomes [<xref ref-type="bibr" rid="CR9">9</xref>&#8211;<xref ref-type="bibr" rid="CR11">11</xref>]. To enhance system performance and design interventions that could accurately identify potential high-risk profiles of vulnerable patients with cancer, modifiable factors that increase the risk of preventable ED visits need to be identified to potentially minimize avoidable morbidity in this vulnerable population [<xref ref-type="bibr" rid="CR12">12</xref>&#8211;<xref ref-type="bibr" rid="CR14">14</xref>].</p><p id="Par15">Prescription opioid use, an important contributor to adverse outcomes, has increased significantly over the past decade, resulting in a spike in acute healthcare use [<xref ref-type="bibr" rid="CR15">15</xref>&#8211;<xref ref-type="bibr" rid="CR17">17</xref>]. Pain control is an important cancer care component; cancer patients are at increased risk of opioid-related adverse outcomes, which, in turn, are associated with increased healthcare burden, as up to 40% of them suffer from chronic pain, and may necessiate long-term opioid use [<xref ref-type="bibr" rid="CR18">18</xref>]. Several studies have estimated the risk of frequent emergency department (FED) use in relationship to patient- and heathcare-related characteristics, and found that young adults, females, having multiple healthcare providers, and chronic conditions were associated with increased risk of FED use [<xref ref-type="bibr" rid="CR19">19</xref>&#8211;<xref ref-type="bibr" rid="CR22">22</xref>]. However, most of the focus of previous research has been on patient-related factors, and the current evidence is limited to health measures captured in administrative data, which offer incomplete documentation of patients&#8217; health and treatment trajectory. These databases do not have data on hospital-level characteristics or in-hospital medication use. As a result, the potential impact of opioid use, administered in hospital, given as part of a discharge treatment regimen or post-discharge dispensations have received little attention, despite important variations in the risk of acute healthcare services use associated with different patterns and durations of opioid use [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Moreover, no study to date has accounted for the risk of competing events such as death [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. FED use, especially in clinical oncology, represent a complex phenomenon, where patient overall health status and frailty may preclude the occurrence of a subsequent healtchare encounter [<xref ref-type="bibr" rid="CR26">26</xref>].</p><p id="Par16">The purpose of this study was to identify patents at high risk of FED use post discharge using comprehensive inpatient, outpatient and community-based clinical and population-based administrative databases. A particular focus was placed on the unexplored role of hospital-related determinants and opioid use characteristics.</p></sec><sec id="Sec2"><title>Methods</title><sec id="Sec3"><title>Study design &amp; setting</title><p id="Par17">The study was performed using the cohort of cancer patients enrolled in a cluster-randomized trial of medication reconciliation conducted at the McGill University Health Centre (MUHC), [<xref ref-type="bibr" rid="CR27">27</xref>] a&#8201;&gt;&#8201;1000-bed quaternary care teaching hospital in Montreal (Canada) that operates within the universal healthcare plan of the province of Quebec (RAMQ). This RAMQ covers all necessary medical care and includes drug insurance for registrants 65 years of age and older, income security recipients, and those not insured through their employer (approximately 50% of the 8.5&#160;million Quebec population). Ethics approval was provided by the MUHC Ethics Committee Board. Quebec privacy commissioner approval was obtained to link clinical and administrative data from the Quebec Privacy Commissioner. Signed informed consent was provided by all participants. This study adheres to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline for observational studies [<xref ref-type="bibr" rid="CR28">28</xref>].</p></sec><sec id="Sec4"><title>Participants</title><p id="Par18">A prospective cohort of cancer patients with non-metastatic disease (stage I-III) admitted to medical and surgical units between October 2014 and November 2016 was followed one-year post-discharge. Patients had to be 18 years of age or older at admission, admitted from the community or transferred from another hospital or ER, with at least one-year continuous provincial healthcare coverage prior to admission. Furthermore, patients had to be discharged alive and have an active confirmed diagnosis of cancer (ICD9:1400&#8211;1999; ICD10: C77-C80, C18-20, C33, C45, C61), in the 12 months prior to or at admission. To assess the associations between initial opioid prescription characteristics, patients had to fill at least one opioid prescription post-discharge before their first occurrence of a post-discharge ED encounter.</p></sec><sec id="Sec5"><title>Data sources</title><p id="Par19">Multiple data sources were assembled and linked to address the study objectives. For each patient, admission and discharge dates, discharge unit, patient demographics, active co-morbidities, and interventions received during hospitalization were retrieved from the hospital discharge abstract database. Community-based, ER and hospital-based medical services, and medication use in the year prior to and after the hospitalization were retrieved from RAMQ&#8217;s medical and pharmacy administrative claims data. In-hospital medications as well as those prescribed at discharge were retrieved from the MUHC drug information system. Combining these data sources provided a complete record of both community-based and in-hospital medication use. Additional information pertaining to the hospital stay was abstracted from the medical chart. Medical conditions and comorbidities were coded from administrative claims using the International Classification of Disease 9th revision (ICD9 codes) and medications were classified according to the Anatomical Therapeutic Chemical Classification System code (ATC). Types of surgery were coded and classified using the Canadian Classification of Health Interventions (CCI).</p></sec><sec id="Sec6"><title>FED use and predictors</title><sec id="FPar4"><title>Emergency department use</title><p id="Par20">The main outcome was FED use (&#8805;&#8201;4 ED visits) in the year following hospital discharge and it was ascertained using the provincial RAMQ medical services claims databases. This definition for FED use was based on the most widely used definition found in the available literature and was deemed to represent a valid threshold [<xref ref-type="bibr" rid="CR29">29</xref>&#8211;<xref ref-type="bibr" rid="CR32">32</xref>].</p></sec><sec id="FPar41145"><title>Patient-related characteristics</title><p id="Par21">For patient-related factors, RAMQ drug programs and hospital charts were used to collect information on age at admission and sex, as these characteristics were shown to be associated with FED visits in previous studies [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. Patients&#8217; income-indexed copayment plan for medications was used as a proxy for socioeconomic status since employment status, and higher income have been associated with lower rates of FED use in previous studies [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. Under Quebec&#8217;s public drug insurance plan, patients could fall into one of three income-based copayment plans: 1) no copayment (free medications), 2) partial copayment (25% per prescription up to a maximum of $600 annually), or 3) maximum copayment (25% per prescription up to a maximum of $1,000 annually). Baseline comorbidities were measured using the Charlson Comorbidity Index (CCI). Specific comorbidities, with known associations were also investigated. These included targeted psycho-social (history of mental health diagnoses, substance and/or alcohol abuse/dependence), and physical comorbidities (cardiovascular disease, renal disease, respiratory diseases, pneumonia, chronic obstructive pulmonary disease, chronic pain). Type of cancer diagnosis (tumor site) in the year prior to admission and updated during the hospital stay (see Supplementary Material Appendix <xref rid="MOESM1" ref-type="media">A</xref> for a full list of covariates included in the model).</p></sec><sec id="FPar5"><title>Healthcare utilization</title><p id="Par22">Using RAMQ medical services databases in the one year prior to admission, we collected information on the receipt of radiotherapy and/or chemotherapy services, number of outpatient visits, number of prescribing physicians, dispensing pharmacies, and the occurrence of a hospitalization or ED visit in the past year.</p></sec><sec id="FPar6"><title>Medication use and hospital characteristics</title><p id="Par23">Pre-admission use of opioids, benzodiazepine, non-opioid analgesics and antidepressant were measured using the RAMQ prescription claims database in the 12 months prior to admission as well as during the index hospitalization using data from the hospital pharmacy system. In-hospital characteristics including the reason for the index admission, type of surgery received, length of hospital stay, admission to the intensive care unit (ICU), discharge destination were retrieved from the MED-ECHO hospitalization database and the use of electronic medication reconciliation software to finalize the discharge prescription.</p></sec><sec id="FPar7"><title>Prescribing physician characteristics</title><p id="Par24">Uniquely to this study, we retrieved organizational and physician&#8217;s characteristics from the hospital data warehouse including physician&#8217;s years in practice, status (resident versus attending physician).</p></sec><sec id="FPar722"><title>Opioid discharge prescription and initial opioid dispensation characteristics</title><p id="Par25">Treatment changes made to opioid medications from the community were evaluated by using patients&#8217; discharge prescriptions data in comparison to their community drug list. These methods were previously described elsewhere [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. Briefly, a categorical variable for whether a given opioid was stopped, continued or newly prescribed was derived. A binary variable for the presence of an opioid as part of the discharge pain regimen was constructed: patients with newly added or continued opioids were flagged as having an opioid prescription. The first post-discharge opioid molecule (e.g., oxycodone, hydromorphone), dose (converted to morphine milligram equivalents (MME) formulation (short-acting vs long-acting), duration, and number of opioid prescriptions dispensed on the same day were measured using RAMQ pharmacy claims (Supplementary Material, Appendix <xref rid="MOESM1" ref-type="media">B-C</xref>).</p></sec></sec><sec id="Sec7"><title>Statistical analyses</title><p id="Par26">Descriptive statistics were used to characterize cancer patients who became FED users compared to those who did not [<xref ref-type="bibr" rid="CR37">37</xref>]. Multivariable Cox Proportional Hazards (PH) models were utilized to determine the association between patient-, drug- and system-level characteristics and FED use. Start of follow-up corresponded to the discharge date from the index hospitalization. End of follow-up corresponded to the day when the patient first met the definition of FED user, death, or to the end of the 12 month follow-up, whichever occurred first. The Lunn-McNeil (LM) approach for competing risk analyses extended to Cox PH models was used to account for the possibility of death during the follow-up period [<xref ref-type="bibr" rid="CR38">38</xref>&#8211;<xref ref-type="bibr" rid="CR40">40</xref>]. Event indicator variables were created for the corresponding event types (either FED use or death). The LM method uses a data augmentation approach to estimate a single completing risk model, which stratifies the results by the distinct baseline hazards for each event type [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. Final variables included in the model were based on backward selection with a p-value of 0.1 used for a variable inclusion with the exception of patient age and sex that were included to minimize residual confounding. The &#8220;events-per-variable&#8221; rule was used to guide the final number of variables in the model (excluding characteristics of the initial opioid dispensation), with an event-to-variable ratio of 10 [<xref ref-type="bibr" rid="CR42">42</xref>]. For each covariate, the results were presented as adjusted hazard ratios (aHR), with 95% confidence intervals (CI). We tested the PH assumption, both globally and for each covariate in the multivariable Cox model, using the Grambsch and Therneau approach [<xref ref-type="bibr" rid="CR43">43</xref>]. For covariates for which the PH hypothesis was violated (p&#8201;&lt;&#8201;0.05), we relied on smooth residual plots to assess how the corresponding adjusted hazard ratio varied over the follow-up (Supplementary Material Appendix <xref rid="MOESM1" ref-type="media">D</xref>). Additionally, we also examined the reasons for the ED visits, as documented in the medical claims databases, to provide additional information about the type of visits the frequent and non-frequent ED users experienced during the follow-up period (Appendix <xref rid="MOESM1" ref-type="media">E</xref>).</p><p id="Par27">To investigate the association between characteristics of the initial opioid dispensation and FED use, we ran a separate Cox PH model accounting for all variables, including the opioid-related factors in the backward selection, but only among patients who filled at last one opioid prescription post-discharge. This additional eligibility restriction was necessary in order to avoid immortal time-bias as well as to reduce confounding by disease severity by only comparing these characteristics among opioid users [<xref ref-type="bibr" rid="CR44">44</xref>, <xref ref-type="bibr" rid="CR45">45</xref>]. To maintain an appropriate temporal sequence that properly places the exposure relative to when the outcome occurs, only patients who filled their first post-discharge opioid prescription before they had their first post-discharge ED encounter were included in the model [<xref ref-type="bibr" rid="CR46">46</xref>]. Cohort entry for this model was time of first dispensation to further reduce the opportunity for immortal time bias [<xref ref-type="bibr" rid="CR47">47</xref>].</p><p id="Par28">All analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC) and statistical models were analyzed using R (R Core Team, 2017).</p></sec></sec><sec id="Sec8" sec-type="results"><title>Results</title><p id="Par29">A total of 1253 cancer patients (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>) were discharged during the study period, with a mean age of 70.9 years. Of these, 57.5% were male, and 41.8% were discharged from a medical service (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). The most frequent cancers were respiratory (38.9%) and upper digestive (24.7%) (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>).</p><p id="Par30">
<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Flowchart of eligible cancer patients</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e491" position="float" orientation="portrait" xlink:href="12913_2023_9854_Fig1_HTML.jpg"/></fig>
</p><p id="Par31">
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Baseline characteristics of cancer patients according to their frequency of emergency department use</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">Overall<break/>n&#8201;=&#8201;1253</th><th align="left" colspan="1" rowspan="1">Non-Frequent Users<break/>(0&#8211;3 ED visits)<break/>n&#8201;=&#8201;1071 (85.5%)</th><th align="left" colspan="1" rowspan="1">Frequent Users<break/>(&#8805;&#8201;4 ED visits)<break/>n&#8201;=&#8201;182 (14.5%)</th></tr></thead><tbody><tr><td align="left" colspan="4" rowspan="1">
<bold>Patient-related characteristics</bold>
</td></tr><tr><td align="left" colspan="4" rowspan="1">
<bold>Age at admission (years)</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Mean age (SD)</td><td align="left" colspan="1" rowspan="1">70.9 (11.8)</td><td align="left" colspan="1" rowspan="1">71.3 (11.8)</td><td align="left" colspan="1" rowspan="1">69.1 (11.5)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8804;64</td><td align="left" colspan="1" rowspan="1">300 (23.9)</td><td align="left" colspan="1" rowspan="1">250 (23.3)</td><td align="left" colspan="1" rowspan="1">50 (27.5)</td></tr><tr><td align="left" colspan="1" rowspan="1">&gt;64</td><td align="left" colspan="1" rowspan="1">953 (76.1)</td><td align="left" colspan="1" rowspan="1">821 (76.7)</td><td align="left" colspan="1" rowspan="1">132 (72.5)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">N (%)</italic></bold>
</td><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">N (%)</italic></bold>
</td><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">N (%)</italic></bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Gender</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Female</td><td align="left" colspan="1" rowspan="1">532 (42.5)</td><td align="left" colspan="1" rowspan="1">459 (42.9)</td><td align="left" colspan="1" rowspan="1">73 (40.1)</td></tr><tr><td align="left" colspan="1" rowspan="1">Male</td><td align="left" colspan="1" rowspan="1">721 (57.5)</td><td align="left" colspan="1" rowspan="1">612 (57.1)</td><td align="left" colspan="1" rowspan="1">109 (59.9)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Medication copayment plan</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">No copayment</td><td align="left" colspan="1" rowspan="1">196 (15.6)</td><td align="left" colspan="1" rowspan="1">161 (15.0)</td><td align="left" colspan="1" rowspan="1">35 (19.2)</td></tr><tr><td align="left" colspan="1" rowspan="1">Partial copayment</td><td align="left" colspan="1" rowspan="1">294 (23.5)</td><td align="left" colspan="1" rowspan="1">248 (23.2)</td><td align="left" colspan="1" rowspan="1">46 (25.3)</td></tr><tr><td align="left" colspan="1" rowspan="1">Maximum copayment</td><td align="left" colspan="1" rowspan="1">763 (60.9)</td><td align="left" colspan="1" rowspan="1">662 (61.8)</td><td align="left" colspan="1" rowspan="1">101 (55.5)</td></tr><tr><td align="left" colspan="4" rowspan="1">
<bold>Healthcare use in the one year pre-admission period</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">Mean (SD)</italic></bold>
</td><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">Mean (SD)</italic></bold>
</td><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">Mean (SD)</italic></bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Emergency department (ED) visits</td><td align="left" colspan="1" rowspan="1">9.2 (14.5)</td><td align="left" colspan="1" rowspan="1">8.5 (14.3)</td><td align="left" colspan="1" rowspan="1">13.0 (15.5)</td></tr><tr><td align="left" colspan="1" rowspan="1">Hospitalizations</td><td align="left" colspan="1" rowspan="1">0.93 (2.21)</td><td align="left" colspan="1" rowspan="1">0.89 (2.3)</td><td align="left" colspan="1" rowspan="1">1.1 (1.8)</td></tr><tr><td align="left" colspan="1" rowspan="1">Ambulatory visits</td><td align="left" colspan="1" rowspan="1">14.5 (12.1)</td><td align="left" colspan="1" rowspan="1">14.1 (12.2)</td><td align="left" colspan="1" rowspan="1">16.9 (10.9)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">N (%)</italic></bold>
</td><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">N (%)</italic></bold>
</td><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">N (%)</italic></bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Radiotherapy</td><td align="left" colspan="1" rowspan="1">192 (15.3)</td><td align="left" colspan="1" rowspan="1">138 (12.9)</td><td align="left" colspan="1" rowspan="1">54 (29.7)</td></tr><tr><td align="left" colspan="1" rowspan="1">Chemotherapy</td><td align="left" colspan="1" rowspan="1">239 (19.1)</td><td align="left" colspan="1" rowspan="1">168 (15.7)</td><td align="left" colspan="1" rowspan="1">71 (39.0)</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">Mean (SD)</italic></bold>
</td><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">Mean (SD)</italic></bold>
</td><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">Mean (SD)</italic></bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Number of prescribing physicians</td><td align="left" colspan="1" rowspan="1">4.8 (3.4)</td><td align="left" colspan="1" rowspan="1">4.6 (3.2)</td><td align="left" colspan="1" rowspan="1">5.9 (3.9)</td></tr><tr><td align="left" colspan="1" rowspan="1">Number of dispensing pharmacies</td><td align="left" colspan="1" rowspan="1">1.4 (0.85)</td><td align="left" colspan="1" rowspan="1">1.4 (0.86)</td><td align="left" colspan="1" rowspan="1">1.5 (0.81)</td></tr><tr><td align="left" colspan="1" rowspan="1">Active prescriptions at admission</td><td align="left" colspan="1" rowspan="1">8.7 (9.7)</td><td align="left" colspan="1" rowspan="1">8.5 (9.5)</td><td align="left" colspan="1" rowspan="1">10.2 (11.1)</td></tr><tr><td align="left" colspan="4" rowspan="1">
<bold>Medication use in the one year pre-admission period</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">N (%)</italic></bold>
</td><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">N (%)</italic></bold>
</td><td align="left" colspan="1" rowspan="1">
<bold><italic toggle="yes">N (%)</italic></bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Active opioid prescription at admission</td><td align="left" colspan="1" rowspan="1">207 (16.5)</td><td align="left" colspan="1" rowspan="1">159 (14.9)</td><td align="left" colspan="1" rowspan="1">48 (26.4)</td></tr><tr><td align="left" colspan="1" rowspan="1">History of opioid use</td><td align="left" colspan="1" rowspan="1">505 (40.3)</td><td align="left" colspan="1" rowspan="1">407 (38.0)</td><td align="left" colspan="1" rowspan="1">98 (53.9)</td></tr><tr><td align="left" colspan="1" rowspan="1">History of &gt;&#8201;3 opioid dispensations</td><td align="left" colspan="1" rowspan="1">45 (3.6)</td><td align="left" colspan="1" rowspan="1">37 (3.5)</td><td align="left" colspan="1" rowspan="1">8 (4.4)</td></tr><tr><td align="left" colspan="1" rowspan="1">History of analgesics use</td><td align="left" colspan="1" rowspan="1">505 (40.3)</td><td align="left" colspan="1" rowspan="1">413 (38.6)</td><td align="left" colspan="1" rowspan="1">92 (50.6)</td></tr><tr><td align="left" colspan="1" rowspan="1">History of antidepressant use</td><td align="left" colspan="1" rowspan="1">270 (21.6)</td><td align="left" colspan="1" rowspan="1">226 (21.1)</td><td align="left" colspan="1" rowspan="1">44 (24.2)</td></tr><tr><td align="left" colspan="1" rowspan="1">History of benzodiazepines</td><td align="left" colspan="1" rowspan="1">503 (40.1)</td><td align="left" colspan="1" rowspan="1">403 (37.6)</td><td align="left" colspan="1" rowspan="1">100 (54.9)</td></tr><tr><td align="left" colspan="4" rowspan="1">
<bold>Targeted comorbidities that may increase the risk of hospitalizations/ED visits</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Charlson Comorbidity Index</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">0</td><td align="left" colspan="1" rowspan="1">14 (1.1)</td><td align="left" colspan="1" rowspan="1">14 (1.3)</td><td align="left" colspan="1" rowspan="1">0 (0)</td></tr><tr><td align="left" colspan="1" rowspan="1">1&#8211;2</td><td align="left" colspan="1" rowspan="1">247 (19.7)</td><td align="left" colspan="1" rowspan="1">232 (21.7)</td><td align="left" colspan="1" rowspan="1">15 (8.2)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8805;3</td><td align="left" colspan="1" rowspan="1">992 (79.2)</td><td align="left" colspan="1" rowspan="1">825 (77.0)</td><td align="left" colspan="1" rowspan="1">167 (91.8)</td></tr><tr><td align="left" colspan="1" rowspan="1">Cardiovascular Diseases</td><td align="left" colspan="1" rowspan="1">602 (48.0)</td><td align="left" colspan="1" rowspan="1">508 (47.4)</td><td align="left" colspan="1" rowspan="1">94 (51.7)</td></tr><tr><td align="left" colspan="1" rowspan="1">Cerebrovascular Diseases</td><td align="left" colspan="1" rowspan="1">114 (9.1)</td><td align="left" colspan="1" rowspan="1">92 (8.6)</td><td align="left" colspan="1" rowspan="1">22 (12.1)</td></tr><tr><td align="left" colspan="1" rowspan="1">Pneumonia</td><td align="left" colspan="1" rowspan="1">124 (9.9)</td><td align="left" colspan="1" rowspan="1">101 (9.4)</td><td align="left" colspan="1" rowspan="1">23 (12.6)</td></tr><tr><td align="left" colspan="1" rowspan="1">Chronic obstructive pulmonary disease</td><td align="left" colspan="1" rowspan="1">349 (27.9)</td><td align="left" colspan="1" rowspan="1">292 (27.3)</td><td align="left" colspan="1" rowspan="1">57 (31.3)</td></tr><tr><td align="left" colspan="1" rowspan="1">Diabetes</td><td align="left" colspan="1" rowspan="1">245 (19.6)</td><td align="left" colspan="1" rowspan="1">197 (18.4)</td><td align="left" colspan="1" rowspan="1">48 (26.4)</td></tr><tr><td align="left" colspan="1" rowspan="1">Renal Disease</td><td align="left" colspan="1" rowspan="1">116 (9.3)</td><td align="left" colspan="1" rowspan="1">103 (9.6)</td><td align="left" colspan="1" rowspan="1">13 (7.1)</td></tr><tr><td align="left" colspan="1" rowspan="1">History of mental illness</td><td align="left" colspan="1" rowspan="1">190 (15.2)</td><td align="left" colspan="1" rowspan="1">158 (14.8)</td><td align="left" colspan="1" rowspan="1">32 (17.6)</td></tr><tr><td align="left" colspan="1" rowspan="1">History of substance&amp; alcohol abuse</td><td align="left" colspan="1" rowspan="1">37 (2.9)</td><td align="left" colspan="1" rowspan="1">30 (2.8)</td><td align="left" colspan="1" rowspan="1">7 (3.9)</td></tr><tr><td align="left" colspan="1" rowspan="1">History of pain syndromes</td><td align="left" colspan="1" rowspan="1">515 (41.1)</td><td align="left" colspan="1" rowspan="1">431 (40.2)</td><td align="left" colspan="1" rowspan="1">84 (46.2)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Cancer diagnoses</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Digestive</td><td align="left" colspan="1" rowspan="1">309 (24.7)</td><td align="left" colspan="1" rowspan="1">257 (24.0)</td><td align="left" colspan="1" rowspan="1">52 (28.6)</td></tr><tr><td align="left" colspan="1" rowspan="1">Lung</td><td align="left" colspan="1" rowspan="1">488 (38.9)</td><td align="left" colspan="1" rowspan="1">408 (38.1)</td><td align="left" colspan="1" rowspan="1">80 (43.9)</td></tr><tr><td align="left" colspan="1" rowspan="1">Breast cancer</td><td align="left" colspan="1" rowspan="1">274 (21.9)</td><td align="left" colspan="1" rowspan="1">232 (21.7)</td><td align="left" colspan="1" rowspan="1">42 (23.1)</td></tr><tr><td align="left" colspan="1" rowspan="1">Urologic</td><td align="left" colspan="1" rowspan="1">248 (19.8)</td><td align="left" colspan="1" rowspan="1">214 (19.9)</td><td align="left" colspan="1" rowspan="1">34 (18.7)</td></tr><tr><td align="left" colspan="1" rowspan="1">Unspecified Cancer</td><td align="left" colspan="1" rowspan="1">88 (7.0)</td><td align="left" colspan="1" rowspan="1">76 (7.1)</td><td align="left" colspan="1" rowspan="1">12 (6.6)</td></tr><tr><td align="left" colspan="4" rowspan="1">
<bold>In-hospital medication use</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Antidepressants</td><td align="left" colspan="1" rowspan="1">220 (17.6)</td><td align="left" colspan="1" rowspan="1">184 (17.2)</td><td align="left" colspan="1" rowspan="1">36 (19.8)</td></tr><tr><td align="left" colspan="1" rowspan="1">Opioids</td><td align="left" colspan="1" rowspan="1">968 (77.3)</td><td align="left" colspan="1" rowspan="1">826 (77.1)</td><td align="left" colspan="1" rowspan="1">142 (78.0)</td></tr><tr><td align="left" colspan="1" rowspan="1">Benzodiazepines</td><td align="left" colspan="1" rowspan="1">855 (68.2)</td><td align="left" colspan="1" rowspan="1">731 (68.3)</td><td align="left" colspan="1" rowspan="1">124 (68.1)</td></tr><tr><td align="left" colspan="1" rowspan="1">Analgesics</td><td align="left" colspan="1" rowspan="1">1163 (92.8)</td><td align="left" colspan="1" rowspan="1">993 (92.7)</td><td align="left" colspan="1" rowspan="1">170 (93.4)</td></tr><tr><td align="left" colspan="4" rowspan="1">
<bold>Characteristics of the index hospitalization</bold>
</td></tr><tr><td align="left" colspan="4" rowspan="1">
<bold>Reasons for admission</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Cancer</td><td align="left" colspan="1" rowspan="1">368 (29.5)</td><td align="left" colspan="1" rowspan="1">315 (29.5)</td><td align="left" colspan="1" rowspan="1">53 (29.3)</td></tr><tr><td align="left" colspan="1" rowspan="1">Respiratory</td><td align="left" colspan="1" rowspan="1">201 (16.1)</td><td align="left" colspan="1" rowspan="1">180 (16.9)</td><td align="left" colspan="1" rowspan="1">21 (11.6)</td></tr><tr><td align="left" colspan="1" rowspan="1">Cardiovascular</td><td align="left" colspan="1" rowspan="1">177 (14.2)</td><td align="left" colspan="1" rowspan="1">160 (15.0)</td><td align="left" colspan="1" rowspan="1">17 (9.4)</td></tr><tr><td align="left" colspan="1" rowspan="1">Digestive</td><td align="left" colspan="1" rowspan="1">80 (6.4)</td><td align="left" colspan="1" rowspan="1">66 (6.2)</td><td align="left" colspan="1" rowspan="1">14 (7.7)</td></tr><tr><td align="left" colspan="1" rowspan="1">Genitourinary</td><td align="left" colspan="1" rowspan="1">60 (4.8)</td><td align="left" colspan="1" rowspan="1">55 (5.2)</td><td align="left" colspan="1" rowspan="1">5 (2.8)</td></tr><tr><td align="left" colspan="1" rowspan="1">Health services (examinations)</td><td align="left" colspan="1" rowspan="1">43 (3.5)</td><td align="left" colspan="1" rowspan="1">8 (4.4)</td><td align="left" colspan="1" rowspan="1">35 (3.3)</td></tr><tr><td align="left" colspan="1" rowspan="1">Infections</td><td align="left" colspan="1" rowspan="1">36 (2.9)</td><td align="left" colspan="1" rowspan="1">23 (2.2)</td><td align="left" colspan="1" rowspan="1">13 (7.2)</td></tr><tr><td align="left" colspan="1" rowspan="1">Musculoskeletal</td><td align="left" colspan="1" rowspan="1">29 (2.3)</td><td align="left" colspan="1" rowspan="1">25 (2.3)</td><td align="left" colspan="1" rowspan="1">4 (2.2)</td></tr><tr><td align="left" colspan="1" rowspan="1">Injection poisonings</td><td align="left" colspan="1" rowspan="1">20 (1.6)</td><td align="left" colspan="1" rowspan="1">18 (1.7)</td><td align="left" colspan="1" rowspan="1">2 (1.1)</td></tr><tr><td align="left" colspan="1" rowspan="1">Dermatological</td><td align="left" colspan="1" rowspan="1">20 (1.6)</td><td align="left" colspan="1" rowspan="1">16 (1.5)</td><td align="left" colspan="1" rowspan="1">4 (2.2)</td></tr><tr><td align="left" colspan="1" rowspan="1">Immune system</td><td align="left" colspan="1" rowspan="1">17 (1.4)</td><td align="left" colspan="1" rowspan="1">14 (1.3)</td><td align="left" colspan="1" rowspan="1">3 (1.7)</td></tr><tr><td align="left" colspan="1" rowspan="1">Metabolic</td><td align="left" colspan="1" rowspan="1">16 (1.3)</td><td align="left" colspan="1" rowspan="1">9 (0.8)</td><td align="left" colspan="1" rowspan="1">7 (3.9)</td></tr><tr><td align="left" colspan="1" rowspan="1">Other <sup>1</sup></td><td align="left" colspan="1" rowspan="1">165 (13.2)</td><td align="left" colspan="1" rowspan="1">137 (12.8)</td><td align="left" colspan="1" rowspan="1">28 (15.4)</td></tr><tr><td align="left" colspan="1" rowspan="1">Neurological/behavioral</td><td align="left" colspan="1" rowspan="1">11 (0.9)</td><td align="left" colspan="1" rowspan="1">10 (9.3)</td><td align="left" colspan="1" rowspan="1">1 (5.5)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Received surgery</bold>
</td><td align="left" colspan="1" rowspan="1">639 (51.0)</td><td align="left" colspan="1" rowspan="1">563 (52.6)</td><td align="left" colspan="1" rowspan="1">76 (41.7)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">&#8195;Type of Surgery Received</italic>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Cardiac</td><td align="left" colspan="1" rowspan="1">118 (9.4)</td><td align="left" colspan="1" rowspan="1">108 (10.1)</td><td align="left" colspan="1" rowspan="1">10 (5.5)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Gastrointestinal</td><td align="left" colspan="1" rowspan="1">49 (3.9)</td><td align="left" colspan="1" rowspan="1">44 (4.1)</td><td align="left" colspan="1" rowspan="1">5 (2.8)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Thoracic</td><td align="left" colspan="1" rowspan="1">417 (33.3)</td><td align="left" colspan="1" rowspan="1">358 (33.4)</td><td align="left" colspan="1" rowspan="1">59 (32.4)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Unrelated</td><td align="left" colspan="1" rowspan="1">55 (4.4)</td><td align="left" colspan="1" rowspan="1">53 (4.9)</td><td align="left" colspan="1" rowspan="1">2 (1.1)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Length of hospital stay, days</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Mean (SD)</td><td align="left" colspan="1" rowspan="1">8.9 (11.6)</td><td align="left" colspan="1" rowspan="1">8.7 (11.7)</td><td align="left" colspan="1" rowspan="1">8.6 (11.4)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&lt;6</td><td align="left" colspan="1" rowspan="1">166 (13.3)</td><td align="left" colspan="1" rowspan="1">143 (13.4)</td><td align="left" colspan="1" rowspan="1">23 (12.6)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8805;6</td><td align="left" colspan="1" rowspan="1">1087 (86.8)</td><td align="left" colspan="1" rowspan="1">928 (86.6)</td><td align="left" colspan="1" rowspan="1">159 (87.4)</td></tr><tr><td align="left" colspan="1" rowspan="1">Admission to the ICU</td><td align="left" colspan="1" rowspan="1">97 (7.7)</td><td align="left" colspan="1" rowspan="1">81 (7.7)</td><td align="left" colspan="1" rowspan="1">16 (8.8)</td></tr><tr><td align="left" colspan="1" rowspan="1">Medication reconciliation used</td><td align="left" colspan="1" rowspan="1">291 (23.2)</td><td align="left" colspan="1" rowspan="1">255 (23.8)</td><td align="left" colspan="1" rowspan="1">36 (19.8)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Attending physician years of practice</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;1&#8211;20</td><td align="left" colspan="1" rowspan="1">350 (27.9)</td><td align="left" colspan="1" rowspan="1">291 (27.2)</td><td align="left" colspan="1" rowspan="1">59 (32.4)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;20&#8211;40</td><td align="left" colspan="1" rowspan="1">661 (52.8)</td><td align="left" colspan="1" rowspan="1">575 (53.7)</td><td align="left" colspan="1" rowspan="1">86 (47.3)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&gt;40</td><td align="left" colspan="1" rowspan="1">242 919.3)</td><td align="left" colspan="1" rowspan="1">205 (19.1)</td><td align="left" colspan="1" rowspan="1">37 (20.3)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Discharge prescription signed by</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Attending physician</td><td align="left" colspan="1" rowspan="1">280 (22.3)</td><td align="left" colspan="1" rowspan="1">241 (22.5)</td><td align="left" colspan="1" rowspan="1">39 (21.4)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Resident</td><td align="left" colspan="1" rowspan="1">973 (77.6)</td><td align="left" colspan="1" rowspan="1">830 (77.5)</td><td align="left" colspan="1" rowspan="1">143 (78.6)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Home discharge destination</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Home</td><td align="left" colspan="1" rowspan="1">1147 (91.5)</td><td align="left" colspan="1" rowspan="1">975 (91.0)</td><td align="left" colspan="1" rowspan="1">172 (94.5)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Long-term care facility</td><td align="left" colspan="1" rowspan="1">106 (8.5)</td><td align="left" colspan="1" rowspan="1">96 (8.9)</td><td align="left" colspan="1" rowspan="1">10 (5.5)</td></tr><tr><td align="left" colspan="4" rowspan="1">
<bold>Pain regimen at discharge</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Opioid prescription</td><td align="left" colspan="1" rowspan="1">1017 (81.2)</td><td align="left" colspan="1" rowspan="1">870 (81.2)</td><td align="left" colspan="1" rowspan="1">147 (80.8)</td></tr><tr><td align="left" colspan="1" rowspan="1">Analgesic prescription</td><td align="left" colspan="1" rowspan="1">814 (64.9)</td><td align="left" colspan="1" rowspan="1">694 (64.8)</td><td align="left" colspan="1" rowspan="1">120 (65.9)</td></tr><tr><td align="left" colspan="4" rowspan="1">
<bold>Characteristics of the initial opioid dispensation post-discharge</bold>
<sup><bold>2,3</bold></sup>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Filled an opioid prescription post-discharge</td><td align="left" colspan="1" rowspan="1">475 (37.9)</td><td align="left" colspan="1" rowspan="1">357 (33.3)</td><td align="left" colspan="1" rowspan="1">118 (64.8)</td></tr><tr><td align="left" colspan="1" rowspan="1">Filled an opioid prescription within 30 days&#8217; post-discharge</td><td align="left" colspan="1" rowspan="1">444 (93.5)</td><td align="left" colspan="1" rowspan="1">331 (92.7)</td><td align="left" colspan="1" rowspan="1">113 (95.8)</td></tr><tr><td align="left" colspan="1" rowspan="1">Filled &#8805;1 type of opioid</td><td align="left" colspan="1" rowspan="1">36 (7.6)</td><td align="left" colspan="1" rowspan="1">26 (7.3)</td><td align="left" colspan="1" rowspan="1">10 (8.5)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>MME Dose</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8804;20</td><td align="left" colspan="1" rowspan="1">100 (21.1)</td><td align="left" colspan="1" rowspan="1">74 (20.7)</td><td align="left" colspan="1" rowspan="1">26 (22.0)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;20&#8211;50</td><td align="left" colspan="1" rowspan="1">267 (56.2)</td><td align="left" colspan="1" rowspan="1">201 (56.3)</td><td align="left" colspan="1" rowspan="1">66 (55.9)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;50&#8211;90</td><td align="left" colspan="1" rowspan="1">93 (19.6)</td><td align="left" colspan="1" rowspan="1">73 (20.5)</td><td align="left" colspan="1" rowspan="1">20 (16.9)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&gt;90</td><td align="left" colspan="1" rowspan="1">15 (3.2)</td><td align="left" colspan="1" rowspan="1">9 (2.5)</td><td align="left" colspan="1" rowspan="1">6 (5.1)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Days&#8217; Supply</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8804;7</td><td align="left" colspan="1" rowspan="1">238 (50.1)</td><td align="left" colspan="1" rowspan="1">181 (50.7)</td><td align="left" colspan="1" rowspan="1">57 (48.3)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&gt;7</td><td align="left" colspan="1" rowspan="1">237 (49.9)</td><td align="left" colspan="1" rowspan="1">176 (49.3)</td><td align="left" colspan="1" rowspan="1">61 (51.7)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Formulation</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Short-acting</td><td align="left" colspan="1" rowspan="1">444 (93.5)</td><td align="left" colspan="1" rowspan="1">335 (93.8)</td><td align="left" colspan="1" rowspan="1">109 (92.4)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Long-acting</td><td align="left" colspan="1" rowspan="1">31 (6.5)</td><td align="left" colspan="1" rowspan="1">22 (6.2)</td><td align="left" colspan="1" rowspan="1">9 (7.6)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Type of opioid</bold>
</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Codeine</td><td align="left" colspan="1" rowspan="1">10 (2.1)</td><td align="left" colspan="1" rowspan="1">9 (1.9)</td><td align="left" colspan="1" rowspan="1">1(0.9)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Hydromorphone</td><td align="left" colspan="1" rowspan="1">151 (31.8)</td><td align="left" colspan="1" rowspan="1">104 (29.1)</td><td align="left" colspan="1" rowspan="1">47 (39.8)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Oxycodone</td><td align="left" colspan="1" rowspan="1">272 (57.3)</td><td align="left" colspan="1" rowspan="1">215 (60.2)</td><td align="left" colspan="1" rowspan="1">57 (48.3)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Fentanyl</td><td align="left" colspan="1" rowspan="1">9 (1.9)</td><td align="left" colspan="1" rowspan="1">8 (2.2)</td><td align="left" colspan="1" rowspan="1">1 (0.9)</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Methadone</td><td align="left" colspan="1" rowspan="1">2 (0.4)</td><td align="left" colspan="1" rowspan="1">1 (0.3)</td><td align="left" colspan="1" rowspan="1">1 (0.9)</td></tr></tbody></table><table-wrap-foot><p>ED&#8201;=&#8201;emergency department; SD&#8201;=&#8201;standard deviation; ICU&#8201;=&#8201;intensive care unit; MME&#8201;=&#8201;milligram morphine equivalent</p><p><sup>1</sup> Other: pain, vomiting, nausea, dizziness, swelling</p><p><sup>2</sup> These numbers are presented only among those who filled an opioid dispensation post-discharge, before their first</p><p>ED visit following the index hospitalization (n&#8201;=&#8201;792)</p><p><sup>3</sup>Percentage of opioid characteristics is calculated based on the total number of patients with at least one dispensation (n&#8201;=&#8201;475)</p></table-wrap-foot></table-wrap>
</p><p id="Par32">Overall, 14.5% (n&#8201;=&#8201;182) of patients became FED users and 19.3% (n&#8201;=&#8201;242) died during the follow-up (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). The mean time of follow-up for FED users was 208.1 days. When compared to patients with &lt;&#8201;4 ED visits, patients who became FED users were more likely to have had a higher mean number of ED (13.0 vs 8.5) and ambulatory visits (16.9 vs 14.1) in the pre-admission year, had received radiotherapy (29.7% vs 12.9%) or chemotherapy during those 12-months (39.0% vs 15.7%), and already had an active opioid prescription at admission (26.4% vs 13.0%). FED users were also more likely to have had a history of opioid (53.9% vs 38.0%), analgesic (50.6% vs 38.6%) and benzodiazepine (54.9% vs 37.6%) use before their admission, as well as have a higher (&#8805;3) CCI index (91.8% vs 77.0%). FED users were less likely to have received surgery during their index hospitalization (41.7% vs 52.6%).</p><p id="Par33">At discharge, 81.2% of patients received an opioid prescription (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>, Table&#160;<xref rid="Tab2" ref-type="table">2</xref>). Most discharge opioid prescriptions were newly initiated, as 62.6% of patients did not have an opioid dispensation in the year proceeding their hospitalization (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>). Once in the community, 37.9% of patients had at least one opioid dispensed, which always preceded their ED visit (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>).</p><p id="Par34">
<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Flowchart of opioid consumption according to cancer patients&#8217; receipt of opioid prescription at discharge, previous history of opioid use and post-discharge dispensations</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d32e1755" position="float" orientation="portrait" xlink:href="12913_2023_9854_Fig2_HTML.jpg"/></fig>
</p><p id="Par35">
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Association between frequent emergency department use and patient-, medication-, and system-related characteristics (n&#8201;=&#8201;1253)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Variable</th><th align="left" colspan="1" rowspan="1">Adjusted HR<sup>1</sup><break/>(95% CI)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">
<bold>Demographics</bold>
</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Age</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&lt;65</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8805;65</td><td align="left" colspan="1" rowspan="1">0.9 (0.7&#8211;1.2)</td></tr><tr><td align="left" colspan="1" rowspan="1">Gender</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Female</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Male</td><td align="left" colspan="1" rowspan="1">1.2 (0.9&#8211;1.6)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<bold>Healthcare use characteristics</bold>
</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Emergency department (ED) visits</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;0</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8805;1</td><td align="left" colspan="1" rowspan="1">
<bold>1.8 (1.2&#8211;2.8)</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Ambulatory visits</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&lt;15</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8805;15</td><td align="left" colspan="1" rowspan="1">1.2 (0.89&#8211;1.7)</td></tr><tr><td align="left" colspan="1" rowspan="1">Radiotherapy</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">1.4 ( 0.91 &#8722;&#8201;2.0)</td></tr><tr><td align="left" colspan="1" rowspan="1">Chemotherapy</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">
<bold>2.6 (1.8&#8211;3.7)</bold>
</td></tr><tr><td align="left" colspan="2" rowspan="1">
<bold>Comorbidities</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Charlson Comorbidity Index</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;0&#8211;2</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8805;3</td><td align="left" colspan="1" rowspan="1">
<bold>2.0 (1.2&#8211;3.4)</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Renal disease</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">0.6 (0.4&#8211;1.1)</td></tr><tr><td align="left" colspan="1" rowspan="1">Diabetes</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">
<bold>1.6 (1.1&#8211;2.2)</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Heart disease</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">
<bold>1.5 (1.1&#8211;2.2)</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Lung cancer</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">
<bold>1.7 (1.1&#8211;2.4)</bold>
</td></tr><tr><td align="left" colspan="2" rowspan="1">
<bold>Medication use</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">History of benzodiazepine use</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">
<bold>1.7 (1.1&#8211;2.4)</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">History of opioid use</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">
<bold>1.4 (1.0&#8211;1.9)</bold>
</td></tr><tr><td align="left" colspan="2" rowspan="1">
<bold>In-hospital characteristics</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">&#8195;Type of surgery</italic>
</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;No surgery</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Cardiac</td><td align="left" colspan="1" rowspan="1">
<bold>0.33 (0.16&#8211;0.66)</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Gastrointestinal</td><td align="left" colspan="1" rowspan="1">
<bold>0.34 (0.14&#8211;0.82)</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Thoracic</td><td align="left" colspan="1" rowspan="1">
<bold>0.45 (0.30&#8211;0.67)</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8195;Unrelated</td><td align="left" colspan="1" rowspan="1">
<bold>0.21 (0.05&#8211;0.89)</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Admission to the ICU</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">1.67 (0.98&#8211;2.8)</td></tr><tr><td align="left" colspan="1" rowspan="1">Hospital LOS, days</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&lt;6</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8805;6</td><td align="left" colspan="1" rowspan="1">1.2 (0.76&#8211;1.8)</td></tr><tr><td align="left" colspan="1" rowspan="1">Discharge prescription for a non-opioid analgesic</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">1.32 (0.95&#8211;1.9)</td></tr></tbody></table><table-wrap-foot><p>HR&#8201;=&#8201;hazard ratio, CI&#8201;=&#8201;confidence interval, LOS&#8201;=&#8201;length of hospital stay</p><p><sup>1</sup>Adjusted for all the variables in the table. Covariate selection was based on backward selection, using a p-value of 0.1 for variable inclusion, as well as a number of characteristics with low p-values. The final number of variables selection was based on the events-per-variable rule, where the total number of variables in the final model did not fall beyond an event-to-variable ratio of 10. Statistically significant findings are bolded. In total, there were 242 patients (19.3%) who had died before having the opportunity to become frequent emergency department users.</p></table-wrap-foot></table-wrap>
</p><p id="Par36">The most common dispensed opioids were oxycodone (57.3%) and hydromorphone (31.8%) (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). With respect to post-discharge opioid consumption, FED users had similar characteristics to non-FED users in terms of the dose, duration and formulation of the first post-discharge opioid prescription but were more likely to have filled a prescription for hydromorphone (39.8% vs 29.1%) (Table&#160;<xref rid="Tab1" ref-type="table">1</xref>).</p><p id="Par37">In the multivariable Cox model (Table&#160;<xref rid="Tab2" ref-type="table">2</xref>), patients who had a history of &#8805; 1 ED visit pre-admission were associated with an increased likelihood of transitioning into a FED user post-discharge (aHR 1.80, 95% CI 1.20&#8211;2.80). Patients receiving chemotherapy preadmission were 2.6 times more likely to become FED users (aHR 2.60, 95% CI, 1.80&#8211;3.70). Having a higher CCI (&#8805;3) (aHR: 2.0, 95% CI: 1.2&#8211;3.4), a history of diabetes (aHR: 1.60, 95% CI: 1.10&#8211;2.20), heart disease (aHR: 1.50, 95% CI: 1.10&#8211;2.20), or lung cancer (aHR: 1.70, 95% CI: 1.10&#8211;2.40), were all independently associated with an increased likelihood of becoming a FED user. Having had surgery (cardiac (aHR: 0.33, 95% CI: 0.16&#8211;0.66), gastrointestinal (aHR: 0.34, 95% CI: 0.14&#8211;0.82) and thoracic (aHR: 0.45, 95% CI: 0.30&#8211;0.67) led to a decreased risk of FED use. Patients with a preadmission history of opioid use had a 40% higher risk of becoming FED users during the one-year post-discharge (aHR 1.40, 95% CI 1.10&#8211;1.90) and a 70% increased risk of FED use with a history of benzodiazepine use (aHR 1.70, 95% CI 1.10&#8211;2.20). In the subset of 475 (37.9%) of patients who filled at least one opioid dispensation post discharge, having had &#8805;15 ambulatory visits (aHR 1.54 95% CI 1.06&#8211;2.34) preadmission was also associated with FED use (as compared to the main model) (Table&#160;<xref rid="Tab3" ref-type="table">3</xref>)</p><p id="Par38">
<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Association between frequent emergency department use and patient-, medication-, system- and opioid-related characteristics among patients who filled an opioid prescription before their first post-discharge emergency department visit (n&#8201;=&#8201;475)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Variable</th><th align="left" colspan="1" rowspan="1">Adjusted HR<sup>1</sup><break/>(95% CI)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">
<bold>Healthcare use characteristics</bold>
</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Emergency department (ED) visits</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;0</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8805;1</td><td align="left" colspan="1" rowspan="1">
<bold>1.73 (1.08&#8211;2.75)</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Ambulatory visits</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&lt;15</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;&#8805;15</td><td align="left" colspan="1" rowspan="1">
<bold>1.54 (1.06&#8211;2.34)</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Chemotherapy</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">
<bold>2.05 (1.40&#8211;3.00)</bold>
</td></tr><tr><td align="left" colspan="2" rowspan="1">
<bold>Comorbidities</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Renal disease</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">0.46 (0.20&#8211;1.26)</td></tr><tr><td align="left" colspan="1" rowspan="1">Heart disease</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">
<bold>1.95 (1.27&#8211;2.97)</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Diabetes</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">
<bold>1.75 (1.14&#8211;2.69)</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Lung cancer</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">
<bold>1.71 (1.07&#8211;2.74)</bold>
</td></tr><tr><td align="left" colspan="2" rowspan="1">
<bold>Medication use</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Active opioid prescription at admission</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">Ref</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">0.83 (0.52&#8211;1.32)</td></tr><tr><td align="left" colspan="2" rowspan="1">
<bold>In-hospital characteristics</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Antidepressant use</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">Ref</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">1.19 (0.76&#8211;1.87)</td></tr><tr><td align="left" colspan="1" rowspan="1">
<italic toggle="yes">Type of surgery</italic>
</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No surgery</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Cardiac</td><td align="left" colspan="1" rowspan="1">
<bold>0.18 (0.06&#8211;0.49)</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Gastrointestinal</td><td align="left" colspan="1" rowspan="1">
<bold>0.35 (0.14&#8211;0.93)</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Thoracic</td><td align="left" colspan="1" rowspan="1">
<bold>0.42 (0.26&#8211;0.70)</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Unrelated</td><td align="left" colspan="1" rowspan="1">
<bold>0.18 (0.04&#8211;0.80)</bold>
</td></tr><tr><td align="left" colspan="1" rowspan="1">Admission to the ICU</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">2.20 (0.99&#8211;4.88)</td></tr><tr><td align="left" colspan="1" rowspan="1">Discharge prescription for an opioid medication</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;No</td><td align="left" colspan="1" rowspan="1">Reference</td></tr><tr><td align="left" colspan="1" rowspan="1">&#8195;Yes</td><td align="left" colspan="1" rowspan="1">1.53 (0.95&#8211;2.47)</td></tr></tbody></table><table-wrap-foot><p>HR&#8201;=&#8201;hazard ratio, CI&#8201;=&#8201;confidence interval, LOS&#8201;=&#8201;length of hospital stay</p><p><sup>1</sup>Adjusted for all the variables in the table. Covariate selection was based on backward selection, using a p-value of 0.1 for variable inclusion, as well as a number of characteristics with low p-values. The final number of variables selection was based on the events-per-variable rule, where the total number of variables in the final model did not fall beyond an event-to-variable ratio of 10. Statistically significant findings are bolded. In total, there were 92 patients (19.4%) who had died before having the opportunity to become frequent emergency department users.</p></table-wrap-foot></table-wrap>
</p><p id="Par39">The PH hypothesis was rejected by the global test (p&#8201;=&#8201;0.021 and for three of the selected covariates (p&#8201;&lt;&#8201;0.05 for each). Appendix <xref rid="MOESM1" ref-type="media">D</xref> of the Supplementary Material describes how the corresponding aHR&#8217;s of each of these covariates varied with increasing follow-up.</p><p id="Par40">With respect to the reasons for the ED visits, in Appendix <xref rid="MOESM1" ref-type="media">E</xref>, we see the descriptive breakdown comparing the most common documented reasons in the ED visits experienced by non-frequent ED users and the FED users. In the breakdown of the reasons associated with the ED visits (multiple reasons could be documented within the same healthcare encounter), among the FED users, 50% of the visits were for cancer-related diagnoses, as compared to 36.6% for the non-frequent users. We also observed higher percentage of documented reasons for infections and cardiovascular related symptoms. The percentage of visits related to the receipt of clinical follow-up care within the ED setting was similar across non-frequent ED users and FED users.</p></sec><sec id="Sec9" sec-type="discussion"><title>Discussion</title><p id="Par41">We found that cancer patients recently discharged from hospital are at risk of FED visits. Higher pre-admission ED use, ambulatory visits, receipt of radiotherapy and/or chemotherapy, a greater number of comorbidities, a history of heart disease, diabetes, or lung cancer, and pre-admission use of opioids and benzodiazepines were associated with a higher risk of FED use.</p><p id="Par42">Several studies have shown a link between FED use and higher number of past ED visits, history of heart disease, and increased comorbidity profile [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR48">48</xref>&#8211;<xref ref-type="bibr" rid="CR50">50</xref>]. In this study, however, we were able to investigate the potential impact of additional system-level, organizational or opioid related medication factors on FED use [<xref ref-type="bibr" rid="CR29">29</xref>&#8211;<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR51">51</xref>], which led to interesting observations. For example, we found that the receipt of any type of surgery, was associated with a decreased risk of FED use. This finding might be related to the implementation of standardized care pathways that include discharge planning and better follow-up protocols [<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]. However, this finding may be a reflection of having patients in the study cohort that are at an early stage of their cancer disease and, thus, excluding the sickest population; the results should be replicated, in addition to investigating the effect measure modification of having surgery on the risk of FED, using larger cohorts within existent databases that link clinical information to administrative databases.</p><p id="Par43">Previous studies have found opioid dose to be associated with increased risk of long-term opioid use and its associated adverse events [<xref ref-type="bibr" rid="CR54">54</xref>&#8211;<xref ref-type="bibr" rid="CR56">56</xref>]. In our study, we found that opioid prescriptions often went unfilled and opioid use was not associated with increased risk of FED, which may be a reflection of patients included at an early stage of their cancer disease. While our findings showed that initial doses of dispensed opioids did not exceed recommended thresholds and did not lead to increased risk of incurring a high-number of acute healthcare events [<xref ref-type="bibr" rid="CR57">57</xref>], a longer follow-up window may be needed to accurately reflect the role of opioid patterns of use and dose on the risk of FED use. However, over time, patients, progressing to later disease stages, may add several medications to maximize pain control, accumulating longer use over time [<xref ref-type="bibr" rid="CR58">58</xref>&#8211;<xref ref-type="bibr" rid="CR60">60</xref>], which could consequently result in increased risk of opioid-related morbidity and healthcare utilization.</p><p id="Par44">Challenges in cancer-related pain management have highlighted the need to link electronic health records with prescription drug monitoring to better track patients data and provide safe transitions of care [<xref ref-type="bibr" rid="CR61">61</xref>]. In out sudy, we demonstrated that it is possible to link these types of data sources, which, in turn, allowed us to accurately track all in-patient care as well as discharge prescriptions to identify at-risk profiles. Thus, this approach offers the possibility of developing real-time tools that could flag medications&#8217; status at transitions in care, as well as document any complexities in medication regimens that may require further monitoring, and help clinicians to re-evaluate high-risk cancer patients.</p><p id="Par45">The study&#8217;s strengths included comprehensive linked data on each patient&#8217;s care trajectory including detailed clinical data, information on opioid prescription written at the transitions in care, as well as administrative data that enabled us to measure patient attributes that would not normally be feasible. Accessing information from a single, universal health insurance coverage provider further strengthens the findings, by detailing consumption of all healthcare, without regards to type or site. Risk of competing events, a concept first introduced within clinical research in the oncology field [<xref ref-type="bibr" rid="CR62">62</xref>], and particularly important in cancer patients, who are at a higher risk of death, has not been previously explored when assessing predictors of FED use. To our knowledge, this study is the first to investigate patient, system-level and opioid-related characteristics, and provide further insights into the opioid patterns of use that may lead to increased healthcare use using adequate modelling techniques accounting for competing risk of death.</p><p id="Par46">Some limitations of our work merit emphasis. First, this was an observational study and, although we used robust statistical procedures, the results should be interpreted cautiously without inferring causality. We sought to minimize confounding of FED use by severity by including a wealth of detailed information that reflect patient&#8217;s disease severity and medication use. Nevertheless, despite considering the receipt of chemotherapy and radiotherapy, there could still be a possibility for residual confounding by cancer severity. Second, results may not be generalizable to other settings. Third, we used a definition of &#8805;&#8201;4 ED visits to classify frequent users and, since other studies have used thresholds ranging from 4 to 12 visits per year, our results may depend on how frequent use is defined. Fourth, while we presented the documented reasons for the ED visits, we did not study the independent associations with outcome-specific ED visits; we also did not include information on the availability of follow-up care receipt, acknowledging the possibility that some of the ED visits may be truly emergent and necessary given the patient disease profile. Fifth, as part of the prescribing characteristics, we did not look at whether the prescribing physicians were specialists, generalists, or palliative care physicians, and as such, we cannot comment on the role of the type of prescriber in the studied associations; this area should be explored in future avenues of research. Finally, generalizability of our findings may be limited due to studying only stage I-III patients, which excludes the sickest of the population, and represents patients that are at the earliest stage of their cancer progression.</p><p id="Par47">In conclusion, this study used comprehensive data to assess the association between various risk factors with FED use. These results may help hospitals and community health providers to improve the quality of cancer care through providing alternative treatments for high-risk cancer patients.</p></sec><sec sec-type="supplementary-material"><sec id="Sec10"><title>Electronic Supplementary Material</title><p>Below is the link to the electronic supplementary material</p><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="12913_2023_9854_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary Material 1</p></caption></media></supplementary-material>
</p></sec></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><p>Not applicable.</p></ack><notes notes-type="author-contribution"><title>Authors&#8217; contributions</title><p>SK, RT, AM contributed to the study design. SK contributed to the analyses of the data. SK obtained funding as part of her doctoral training. RT obtained the data for this study. SK was responsible for the initial draft of the manuscript. All authors have contributed to the interpretation of the data and the have approved the final article.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This study was not funded by but it was conducted thanks to financial support received by Siyana Kurteva during her doctoral training from the Kuok Fellowship from the Rossy Cancer Network; the Hugh E. Burke Fellowship from the Faculty of Medicine, McGill University; the Drug Safety and Effectiveness Cross-Disciplinary Training Program from the Canadian Institutes for Health Research and the Fonds de Recherche Sant&#233; Quebec; the McGill Cancer Care Quality Initiative.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>Our Research Ethics Board (REB) approval for this project limits data access to Robyn Tamblyn&#8217;s team. To provide access to other researchers, they would need to obtain permission from the Institut de la Statistique du Qu&#233;bec for their project that would use governmental provincial administrative (RAMQ) data. More details regarding eligibility to request data can be found here: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://statistique.quebec.ca/research/#/a-propos/utilisation-guichet">https://statistique.quebec.ca/research/#/a-propos/utilisation-guichet</ext-link>. To use the clinical data, they would have to apply for REB approval for the project, and request that a de-identified copy of the data be made available as consent was provided by patients for only Robyn Tamblyn. More information regarding access to data can be found here: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://statistique.quebec.ca/research/#/demarche/etape-par-etape">https://statistique.quebec.ca/research/#/demarche/etape-par-etape</ext-link>. A link to submit a data request can be found here: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://statistique.quebec.ca/zone-chercheur/#/login">https://statistique.quebec.ca/zone-chercheur/#/login</ext-link>.</p></notes><notes><title>Declarations</title><notes id="FPar3"><title>Ethics approval and consent to participate</title><p id="Par518">All methods were carried out in accordances with institutional guidelines and regulations. Ethics approval was provided by the McGill University Health Centre Ethics Committee Board. Quebec privacy commissioner approval was obtained to link clinical and administrative data from the Quebec Privacy Commissioner. Signed informed consent was provided by all participants. This study adheres to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline for observational studies.</p></notes><notes id="FPar411"><title>Consent for publication</title><p id="Par519">Not applicable.</p></notes><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par517">The authors have no conflict of interest to declare.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Finlayson</surname><given-names>K</given-names></name><name name-style="western"><surname>Chang</surname><given-names>AM</given-names></name><name name-style="western"><surname>Courtney</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Transitional care interventions reduce unplanned hospital readmissions in high-risk older adults</article-title><source>BMC Health Serv Res</source><year>2018</year><volume>18</volume><issue>1</issue><fpage>956</fpage><pub-id pub-id-type="doi">10.1186/s12913-018-3771-9</pub-id><pub-id pub-id-type="pmid">30541530</pub-id><pub-id pub-id-type="pmcid">PMC6291980</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leonardsen</surname><given-names>A-CL</given-names></name><name name-style="western"><surname>Gr&#248;ndahl</surname><given-names>VA</given-names></name><name name-style="western"><surname>Ghanima</surname><given-names>W</given-names></name><etal/></person-group><article-title>Evaluating patient experiences in decentralised acute care using the Picker Patient Experience Questionnaire; methodological and clinical findings</article-title><source>BMC health services research 2017/09/29</source><year>2017</year><volume>17</volume><issue>1</issue><fpage>685</fpage><pub-id pub-id-type="doi">10.1186/s12913-017-2614-4</pub-id><pub-id pub-id-type="pmcid">PMC5622565</pub-id><pub-id pub-id-type="pmid">28962561</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hudon</surname><given-names>C</given-names></name><name name-style="western"><surname>Chouinard</surname><given-names>MC</given-names></name><name name-style="western"><surname>Diadiou</surname><given-names>F</given-names></name><name name-style="western"><surname>Lambert</surname><given-names>M</given-names></name><name name-style="western"><surname>Bouliane</surname><given-names>D</given-names></name></person-group><article-title>Case Management in Primary Care for Frequent Users of Health Care Services With Chronic Diseases: A Qualitative Study of Patient and Family Experience. <italic toggle="yes">Annals of family medicine</italic></article-title><source>Nov</source><year>2015</year><volume>13</volume><issue>6</issue><fpage>523</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1370/afm.1867</pub-id><pub-id pub-id-type="pmcid">PMC4639377</pub-id><pub-id pub-id-type="pmid">26553891</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">Hudon C, Chouinard MC, Dubois MF et al. Case Management in Primary Care for Frequent Users of Health Care Services: A Mixed Methods Study. <italic toggle="yes">Annals of family medicine</italic>. May 2018;16(3):232&#8211;9. 10.1370/afm.2233.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1370/afm.2233</pub-id><pub-id pub-id-type="pmcid">PMC5951252</pub-id><pub-id pub-id-type="pmid">29760027</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sargent</surname><given-names>P</given-names></name><name name-style="western"><surname>Pickard</surname><given-names>S</given-names></name><name name-style="western"><surname>Sheaff</surname><given-names>R</given-names></name><name name-style="western"><surname>Boaden</surname><given-names>R</given-names></name></person-group><article-title>Patient and carer perceptions of case management for long-term conditions</article-title><source>Health &amp; social care in the community Nov</source><year>2007</year><volume>15</volume><issue>6</issue><fpage>511</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2524.2007.00708.x</pub-id><pub-id pub-id-type="pmid">17956403</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williams</surname><given-names>V</given-names></name><name name-style="western"><surname>Smith</surname><given-names>A</given-names></name><name name-style="western"><surname>Chapman</surname><given-names>L</given-names></name><name name-style="western"><surname>Oliver</surname><given-names>D</given-names></name></person-group><article-title>Community matrons&#8211;an exploratory study of patients&#8217; views and experiences</article-title><source>J Adv Nurs Jan</source><year>2011</year><volume>67</volume><issue>1</issue><fpage>86</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2648.2010.05458.x</pub-id><pub-id pub-id-type="pmid">21158904</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brooks</surname><given-names>GA</given-names></name><name name-style="western"><surname>Abrams</surname><given-names>TA</given-names></name><name name-style="western"><surname>Meyerhardt</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Identification of potentially avoidable hospitalizations in patients with GI cancer</article-title><source>J Clin Oncol Feb</source><year>2014</year><volume>20</volume><issue>6</issue><fpage>496</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1200/jco.2013.52.4330</pub-id><pub-id pub-id-type="pmcid">PMC3918534</pub-id><pub-id pub-id-type="pmid">24419123</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vandyk</surname><given-names>AD</given-names></name><name name-style="western"><surname>Harrison</surname><given-names>MB</given-names></name><name name-style="western"><surname>Macartney</surname><given-names>G</given-names></name><name name-style="western"><surname>Ross-White</surname><given-names>A</given-names></name><name name-style="western"><surname>Stacey</surname><given-names>D</given-names></name></person-group><article-title>Emergency department visits for symptoms experienced by oncology patients: a systematic review</article-title><source>Support Care Cancer Aug</source><year>2012</year><volume>20</volume><issue>8</issue><fpage>1589</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1007/s00520-012-1459-y</pub-id><pub-id pub-id-type="pmid">22526151</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bese</surname><given-names>NS</given-names></name><name name-style="western"><surname>Hendry</surname><given-names>J</given-names></name><name name-style="western"><surname>Jeremic</surname><given-names>B</given-names></name></person-group><article-title>Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation</article-title><source>Int J Radiat Oncol Biol Phys Jul</source><year>2007</year><volume>1</volume><issue>3</issue><fpage>654</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1016/j.ijrobp.2007.03.010</pub-id><pub-id pub-id-type="pmid">17467926</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gallaway</surname><given-names>MS</given-names></name><name name-style="western"><surname>Idaikkadar</surname><given-names>N</given-names></name><name name-style="western"><surname>Tai</surname><given-names>E</given-names></name><etal/></person-group><article-title>Emergency department visits among people with cancer: Frequency, symptoms, and characteristics</article-title><source>J Am Coll Emerg Physicians Open Jun</source><year>2021</year><volume>2</volume><issue>3</issue><fpage>e12438</fpage><pub-id pub-id-type="doi">10.1002/emp2.12438</pub-id><pub-id pub-id-type="pmcid">PMC8087934</pub-id><pub-id pub-id-type="pmid">33969353</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mayer</surname><given-names>DK</given-names></name><name name-style="western"><surname>Travers</surname><given-names>D</given-names></name><name name-style="western"><surname>Wyss</surname><given-names>A</given-names></name><name name-style="western"><surname>Leak</surname><given-names>A</given-names></name><name name-style="western"><surname>Waller</surname><given-names>A</given-names></name></person-group><article-title>Why do patients with cancer visit emergency departments? Results of a 2008 population study in North Carolina</article-title><source>J Clin Oncol Jul</source><year>2011</year><volume>1</volume><issue>19</issue><fpage>2683</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1200/jco.2010.34.2816</pub-id><pub-id pub-id-type="pmcid">PMC3139372</pub-id><pub-id pub-id-type="pmid">21606431</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moe</surname><given-names>J</given-names></name><name name-style="western"><surname>Kirkland</surname><given-names>SW</given-names></name><name name-style="western"><surname>Rawe</surname><given-names>E</given-names></name><etal/></person-group><article-title>Effectiveness of Interventions to Decrease Emergency Department Visits by Adult Frequent Users: A Systematic Review</article-title><source>Acad Emerg medicine: official J Soc Acad Emerg Med Jan</source><year>2017</year><volume>24</volume><issue>1</issue><fpage>40</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1111/acem.13060</pub-id><pub-id pub-id-type="pmid">27473387</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitchell</surname><given-names>MS</given-names></name><name name-style="western"><surname>Leon</surname><given-names>CLK</given-names></name><name name-style="western"><surname>Byrne</surname><given-names>TH</given-names></name><name name-style="western"><surname>Lin</surname><given-names>WC</given-names></name><name name-style="western"><surname>Bharel</surname><given-names>M</given-names></name></person-group><article-title>Cost of health care utilization among homeless frequent emergency department users</article-title><source>Psychol Serv May</source><year>2017</year><volume>14</volume><issue>2</issue><fpage>193</fpage><lpage>202</lpage><pub-id pub-id-type="doi">10.1037/ser0000113</pub-id><pub-id pub-id-type="pmid">28481604</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="other">McConville S, Raven MC, Sabbagh SH, Hsia RY. Frequent Emergency Department Users: A Statewide Comparison Before And After Affordable Care Act Implementation. <italic toggle="yes">Health affairs (Project Hope)</italic>. Jun 2018;37(6):881&#8211;9. 10.1377/hlthaff.2017.0784.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1377/hlthaff.2017.0784</pub-id><pub-id pub-id-type="pmid">29863931</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kurteva</surname><given-names>S</given-names></name><name name-style="western"><surname>Abrahamowicz</surname><given-names>M</given-names></name><name name-style="western"><surname>Gomes</surname><given-names>T</given-names></name><name name-style="western"><surname>Tamblyn</surname><given-names>R</given-names></name></person-group><article-title>Association of Opioid Consumption Profiles After Hospitalization With Risk of Adverse Health Care Events</article-title><source>JAMA Netw Open May</source><year>2021</year><volume>3</volume><issue>5</issue><fpage>e218782</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.8782</pub-id><pub-id pub-id-type="pmcid">PMC8132136</pub-id><pub-id pub-id-type="pmid">34003273</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Miller</surname><given-names>M</given-names></name><name name-style="western"><surname>Barber</surname><given-names>CW</given-names></name><name name-style="western"><surname>Leatherman</surname><given-names>S</given-names></name><etal/></person-group><article-title>Prescription opioid duration of action and the risk of unintentional overdose among patients receiving opioid therapy</article-title><source>JAMA Intern Med Apr</source><year>2015</year><volume>175</volume><issue>4</issue><fpage>608</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1001/jamainternmed.2014.8071</pub-id><pub-id pub-id-type="pmid">25686208</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="other">Saunders KW, Dunn KM, Merrill JO, et al. Relationship of opioid use and dosage levels to fractures in older chronic pain patients. J Gen Intern Med. Apr 2010;25(4):310&#8211;5. 10.1007/s11606-009-1218-z.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11606-009-1218-z</pub-id><pub-id pub-id-type="pmcid">PMC2842546</pub-id><pub-id pub-id-type="pmid">20049546</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="other">Paice JA. Navigating Cancer Pain Management in the Midst of the Opioid Epidemic. Oncology (Williston Park, NY). Aug 15 2018;32(8):386 &#8211; 90, 403.<pub-id pub-id-type="pmid">30153316</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galvin</surname><given-names>R</given-names></name><name name-style="western"><surname>Gilleit</surname><given-names>Y</given-names></name><name name-style="western"><surname>Wallace</surname><given-names>E</given-names></name><etal/></person-group><article-title>Adverse outcomes in older adults attending emergency departments: a systematic review and meta-analysis of the Identification of Seniors At Risk (ISAR) screening tool</article-title><source>Age and ageing Mar</source><year>2017</year><volume>1</volume><issue>2</issue><fpage>179</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1093/ageing/afw233</pub-id><pub-id pub-id-type="pmid">27989992</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lash</surname><given-names>RS</given-names></name><name name-style="western"><surname>Bell</surname><given-names>JF</given-names></name><name name-style="western"><surname>Reed</surname><given-names>SC</given-names></name><etal/></person-group><article-title>A Systematic Review of Emergency Department Use Among Cancer Patients. <italic toggle="yes">Cancer nursing</italic></article-title><source>Mar/Apr</source><year>2017</year><volume>40</volume><issue>2</issue><fpage>135</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1097/ncc.0000000000000360</pub-id><pub-id pub-id-type="pmcid">PMC5001935</pub-id><pub-id pub-id-type="pmid">26925998</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="other">Moriya AS, Miller GE. Any Use and Frequent Use of Opioids among Elderly Adults in 2015&#8211;2016, by Socioeconomic Characteristics. Statistical Brief (Medical Expenditure Panel Survey (US)). Agency for Healthcare Research and Quality (US); 2001.<pub-id pub-id-type="pmid">30395428</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scott</surname><given-names>J</given-names></name><name name-style="western"><surname>Strickland</surname><given-names>AP</given-names></name><name name-style="western"><surname>Warner</surname><given-names>K</given-names></name><name name-style="western"><surname>Dawson</surname><given-names>P</given-names></name></person-group><article-title>Frequent callers to and users of emergency medical systems: a systematic review</article-title><source>Emerg Med journal: EMJ Aug</source><year>2014</year><volume>31</volume><issue>8</issue><fpage>684</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1136/emermed-2013-202545</pub-id><pub-id pub-id-type="pmid">23825060</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="other">Kanzaria HK, Niedzwiecki M, Cawley CL et al. Frequent Emergency Department Users: Focusing Solely On Medical Utilization Misses The Whole Person. <italic toggle="yes">Health affairs (Project Hope)</italic>. Nov 2019;38(11):1866&#8211;1875. 10.1377/hlthaff.2019.00082.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1377/hlthaff.2019.00082</pub-id><pub-id pub-id-type="pmid">31682499</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chiu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Racine-Hemmings</surname><given-names>F</given-names></name><name name-style="western"><surname>Dufour</surname><given-names>I</given-names></name><etal/></person-group><article-title>Statistical tools used for analyses of frequent users of emergency department: a scoping review</article-title><source>BMJ Open</source><year>2019</year><volume>9</volume><issue>5</issue><fpage>e027750</fpage><lpage>0</lpage><pub-id pub-id-type="doi">10.1136/bmjopen-2018-027750</pub-id><pub-id pub-id-type="pmid">31129592</pub-id><pub-id pub-id-type="pmcid">PMC6537981</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burns</surname><given-names>TR</given-names></name></person-group><article-title>Contributing factors of frequent use of the emergency department: A synthesis</article-title><source>Int Emerg Nurs Nov</source><year>2017</year><volume>35</volume><fpage>51</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/j.ienj.2017.06.001</pub-id><pub-id pub-id-type="pmid">28676296</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tan</surname><given-names>KS</given-names></name><name name-style="western"><surname>Eguchi</surname><given-names>T</given-names></name><name name-style="western"><surname>Adusumilli</surname><given-names>PS</given-names></name></person-group><article-title>Competing risks and cancer-specific mortality: why it matters</article-title><source>Oncotarget Jan</source><year>2018</year><volume>26</volume><issue>7</issue><fpage>7272</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.23729</pub-id><pub-id pub-id-type="pmcid">PMC5800900</pub-id><pub-id pub-id-type="pmid">29484108</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tamblyn</surname><given-names>R</given-names></name><name name-style="western"><surname>Abrahamowicz</surname><given-names>M</given-names></name><name name-style="western"><surname>Buckeridge</surname><given-names>DL</given-names></name><etal/></person-group><article-title>Effect of an Electronic Medication Reconciliation Intervention on Adverse Drug Events: A Cluster Randomized Trial</article-title><source>JAMA Netw Open</source><year>2019</year><volume>2</volume><issue>9</issue><fpage>e1910756</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2019.10756</pub-id><pub-id pub-id-type="pmid">31539073</pub-id><pub-id pub-id-type="pmcid">PMC6755531</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vandenbroucke</surname><given-names>JP</given-names></name><name name-style="western"><surname>von Elm</surname><given-names>E</given-names></name><name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name><etal/></person-group><article-title>Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration</article-title><source>Annals of internal medicine Oct</source><year>2007</year><volume>16</volume><issue>8</issue><fpage>W163</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-147-8-200710160-00010-w1</pub-id><pub-id pub-id-type="pmid">17938389</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hansagi</surname><given-names>H</given-names></name><name name-style="western"><surname>Olsson</surname><given-names>M</given-names></name><name name-style="western"><surname>Sjoberg</surname><given-names>S</given-names></name><name name-style="western"><surname>Tomson</surname><given-names>Y</given-names></name><name name-style="western"><surname>Goransson</surname><given-names>S</given-names></name></person-group><article-title>Frequent use of the hospital emergency department is indicative of high use of other health care services</article-title><source>Annals of emergency medicine Jun</source><year>2001</year><volume>37</volume><issue>6</issue><fpage>561</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1067/mem.2001.111762</pub-id><pub-id pub-id-type="pmid">11385324</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hunt</surname><given-names>KA</given-names></name><name name-style="western"><surname>Weber</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Showstack</surname><given-names>JA</given-names></name><name name-style="western"><surname>Colby</surname><given-names>DC</given-names></name><name name-style="western"><surname>Callaham</surname><given-names>ML</given-names></name></person-group><article-title>Characteristics of frequent users of emergency departments</article-title><source>Annals of emergency medicine Jul</source><year>2006</year><volume>48</volume><issue>1</issue><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.annemergmed.2005.12.030</pub-id><pub-id pub-id-type="pmid">16781914</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>BC</given-names></name><name name-style="western"><surname>Burstin</surname><given-names>HR</given-names></name><name name-style="western"><surname>Brennan</surname><given-names>TA</given-names></name></person-group><article-title>Predictors and outcomes of frequent emergency department users</article-title><source>Acad Emerg medicine: official J Soc Acad Emerg Med Apr</source><year>2003</year><volume>10</volume><issue>4</issue><fpage>320</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1111/j.1553-2712.2003.tb01344.x</pub-id><pub-id pub-id-type="pmid">12670845</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bieler</surname><given-names>G</given-names></name><name name-style="western"><surname>Paroz</surname><given-names>S</given-names></name><name name-style="western"><surname>Faouzi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Social and medical vulnerability factors of emergency department frequent users in a universal health insurance system</article-title><source>Acad Emerg medicine: official J Soc Acad Emerg Med Jan</source><year>2012</year><volume>19</volume><issue>1</issue><fpage>63</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1111/j.1553-2712.2011.01246.x</pub-id><pub-id pub-id-type="pmid">22221292</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="other">Soril LJ, Leggett LE, Lorenzetti DL, Noseworthy TW, Clement FM. Characteristics of frequent users of the emergency department in the general adult population: A systematic review of international healthcare systems. <italic toggle="yes">Health policy (Amsterdam, Netherlands)</italic>. May 2016;120(5):452 &#8211; 61. 10.1016/j.healthpol.2016.02.006.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.healthpol.2016.02.006</pub-id><pub-id pub-id-type="pmid">26947060</pub-id></mixed-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dufour</surname><given-names>I</given-names></name><name name-style="western"><surname>Chouinard</surname><given-names>MC</given-names></name><name name-style="western"><surname>Dubuc</surname><given-names>N</given-names></name><name name-style="western"><surname>Beaudin</surname><given-names>J</given-names></name><name name-style="western"><surname>Lafontaine</surname><given-names>S</given-names></name><name name-style="western"><surname>Hudon</surname><given-names>C</given-names></name></person-group><article-title>Factors associated with frequent use of emergency-department services in a geriatric population: a systematic review</article-title><source>BMC Geriatr Jul</source><year>2019</year><volume>5</volume><issue>1</issue><fpage>185</fpage><pub-id pub-id-type="doi">10.1186/s12877-019-1197-9</pub-id><pub-id pub-id-type="pmcid">PMC6610907</pub-id><pub-id pub-id-type="pmid">31277582</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="other">Depelteau A, Racine-Hemmings F, Lagueux E, Hudon C. Chronic pain and frequent use of emergency department: A systematic review. Am J Emerg Med Oct. 2019;14. 10.1016/j.ajem.2019.158492.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajem.2019.158492</pub-id><pub-id pub-id-type="pmid">31706663</pub-id></mixed-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kurteva</surname><given-names>S</given-names></name><name name-style="western"><surname>Abrahamowicz</surname><given-names>M</given-names></name><name name-style="western"><surname>Weir</surname><given-names>D</given-names></name><name name-style="western"><surname>Gomes</surname><given-names>T</given-names></name><name name-style="western"><surname>Tamblyn</surname><given-names>R</given-names></name></person-group><article-title>Determinants of long-term opioid use in hospitalized patients</article-title><source>PLoS ONE</source><year>2022</year><volume>17</volume><issue>12</issue><fpage>e0278992</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0278992</pub-id><pub-id pub-id-type="pmid">36520865</pub-id><pub-id pub-id-type="pmcid">PMC9754198</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kragh Andersen</surname><given-names>P</given-names></name><name name-style="western"><surname>Pohar Perme</surname><given-names>M</given-names></name><name name-style="western"><surname>van Houwelingen</surname><given-names>HC</given-names></name><etal/></person-group><article-title>Analysis of time-to-event for observational studies: Guidance to the use of intensity models</article-title><source>Stat Med Jan</source><year>2021</year><volume>15</volume><issue>1</issue><fpage>185</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1002/sim.8757</pub-id><pub-id pub-id-type="pmid">33043497</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lesko</surname><given-names>CR</given-names></name><name name-style="western"><surname>Lau</surname><given-names>B</given-names></name></person-group><article-title>Bias Due to Confounders for the Exposure-Competing Risk Relationship</article-title><source>Epidemiology</source><year>2017</year><volume>28</volume><issue>1</issue><fpage>20</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1097/EDE.0000000000000565</pub-id><pub-id pub-id-type="pmid">27748680</pub-id><pub-id pub-id-type="pmcid">PMC5489237</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lim</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Dyck</surname><given-names>R</given-names></name><name name-style="western"><surname>Osgood</surname><given-names>N</given-names></name></person-group><article-title>Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes</article-title><source>BMC Med Res Methodol</source><year>2010</year><volume>10</volume><fpage>97</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1186/1471-2288-10-97</pub-id><pub-id pub-id-type="pmid">20964855</pub-id><pub-id pub-id-type="pmcid">PMC2988010</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lunn</surname><given-names>M</given-names></name><name name-style="western"><surname>McNeil</surname><given-names>D</given-names></name></person-group><article-title>Applying Cox regression to competing risks</article-title><source>Biometrics Jun</source><year>1995</year><volume>51</volume><issue>2</issue><fpage>524</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.2307/2532940</pub-id><pub-id pub-id-type="pmid">7662841</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Belot</surname><given-names>A</given-names></name><name name-style="western"><surname>Abrahamowicz</surname><given-names>M</given-names></name><name name-style="western"><surname>Remontet</surname><given-names>L</given-names></name><name name-style="western"><surname>Giorgi</surname><given-names>R</given-names></name></person-group><article-title>Flexible modeling of competing risks in survival analysis</article-title><source>Stat Med Oct</source><year>2010</year><volume>15</volume><issue>23</issue><fpage>2453</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1002/sim.4005</pub-id><pub-id pub-id-type="pmid">20645282</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vittinghoff</surname><given-names>E</given-names></name><name name-style="western"><surname>McCulloch</surname><given-names>CE</given-names></name></person-group><article-title>Relaxing the rule of ten events per variable in logistic and Cox regression</article-title><source>Am J Epidemiol Mar</source><year>2007</year><volume>15</volume><issue>6</issue><fpage>710</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1093/aje/kwk052</pub-id><pub-id pub-id-type="pmid">17182981</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="other">Therneau TM, Grambsch PM, Pankratz VS. Penalized Survival Models and Frailty. <italic toggle="yes">Journal of Computational and Graphical Statistics</italic>. 2003/03/01 2003;12(1):156&#8211;175. 10.1198/1061860031365.</mixed-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suissa</surname><given-names>S</given-names></name><name name-style="western"><surname>Dell&#8217;Aniello</surname><given-names>S</given-names></name></person-group><article-title>Time-related biases in pharmacoepidemiology</article-title><source>Pharmacoepidemiol Drug Saf Sep</source><year>2020</year><volume>29</volume><issue>9</issue><fpage>1101</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1002/pds.5083</pub-id><pub-id pub-id-type="pmid">32783283</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="other">Suissa S, Ernst P. Avoiding immortal time bias in observational studies. Eur Respir J Mar. 2020;55(3). 10.1183/13993003.00138-2020.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1183/13993003.00138-2020</pub-id><pub-id pub-id-type="pmid">32198272</pub-id></mixed-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bykov</surname><given-names>K</given-names></name><name name-style="western"><surname>He</surname><given-names>M</given-names></name><name name-style="western"><surname>Franklin</surname><given-names>JM</given-names></name><name name-style="western"><surname>Garry</surname><given-names>EM</given-names></name><name name-style="western"><surname>Seeger</surname><given-names>JD</given-names></name><name name-style="western"><surname>Patorno</surname><given-names>E</given-names></name></person-group><article-title>Glucose-lowering medications and the risk of cancer: A methodological review of studies based on real-world data</article-title><source>Diabetes Obes Metab Sep</source><year>2019</year><volume>21</volume><issue>9</issue><fpage>2029</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1111/dom.13766</pub-id><pub-id pub-id-type="pmcid">PMC6684441</pub-id><pub-id pub-id-type="pmid">31062453</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hern&#225;n</surname><given-names>MA</given-names></name></person-group><article-title>Methods of Public Health Research - Strengthening Causal Inference from Observational Data</article-title><source>N Engl J Med Oct</source><year>2021</year><volume>7</volume><issue>15</issue><fpage>1345</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1056/NEJMp2113319</pub-id><pub-id pub-id-type="pmid">34596980</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Giannouchos</surname><given-names>TV</given-names></name><name name-style="western"><surname>Kum</surname><given-names>HC</given-names></name><name name-style="western"><surname>Foster</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Ohsfeldt</surname><given-names>RL</given-names></name></person-group><article-title>Characteristics and predictors of adult frequent emergency department users in the United States: A systematic literature review</article-title><source>J evaluation Clin Pract Jun</source><year>2019</year><volume>25</volume><issue>3</issue><fpage>420</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1111/jep.13137</pub-id><pub-id pub-id-type="pmid">31044484</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bayoumi</surname><given-names>I</given-names></name><name name-style="western"><surname>Dolovich</surname><given-names>L</given-names></name><name name-style="western"><surname>Hutchison</surname><given-names>B</given-names></name><name name-style="western"><surname>Holbrook</surname><given-names>A</given-names></name></person-group><article-title>Medication-related emergency department visits and hospitalizations among older adults</article-title><source>Can family physician Medecin de famille canadien Apr</source><year>2014</year><volume>60</volume><issue>4</issue><fpage>e217</fpage><lpage>22</lpage><pub-id pub-id-type="pmcid">PMC4046528</pub-id><pub-id pub-id-type="pmid">24733341</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moe</surname><given-names>J</given-names></name><name name-style="western"><surname>Camargo</surname><given-names>CA</given-names></name><name name-style="western"><surname>Davis</surname><given-names>RB</given-names></name><name name-style="western"><surname>Jelinski</surname><given-names>S</given-names></name><name name-style="western"><surname>Rowe</surname><given-names>BH</given-names></name></person-group><article-title>Frequent emergency department use and mortality in patients with substance and opioid use in Alberta: A population-based retrospective cohort study</article-title><source>Cjem Jul</source><year>2019</year><volume>21</volume><issue>4</issue><fpage>482</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1017/cem.2019.15</pub-id><pub-id pub-id-type="pmid">30983561</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><mixed-citation publication-type="other">Slankamenac K, Zehnder M, Langner TO, Krahenmann K, Keller DI. Recurrent Emergency Department Users: Two Categories with Different Risk Profiles. J Clin Med Mar. 2019;9(3). 10.3390/jcm8030333.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/jcm8030333</pub-id><pub-id pub-id-type="pmcid">PMC6463097</pub-id><pub-id pub-id-type="pmid">30857294</pub-id></mixed-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Emes</surname><given-names>M</given-names></name><name name-style="western"><surname>Smith</surname><given-names>S</given-names></name><name name-style="western"><surname>Ward</surname><given-names>S</given-names></name><name name-style="western"><surname>Smith</surname><given-names>A</given-names></name></person-group><article-title>Improving the patient discharge process: implementing actions derived from a soft systems methodology study</article-title><source>Health Syst (Basingstoke)</source><year>2019</year><volume>8</volume><issue>2</issue><fpage>117</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1080/20476965.2018.1524405</pub-id><pub-id pub-id-type="pmid">31275573</pub-id><pub-id pub-id-type="pmcid">PMC6598519</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kurian</surname><given-names>T</given-names></name><name name-style="western"><surname>Stranges</surname><given-names>E</given-names></name><name name-style="western"><surname>Czerlanis</surname><given-names>C</given-names></name></person-group><article-title>Standardization of the Discharge Process for Inpatient Hematology and Oncology Using Plan-Do-Study-Act Methodology Improves Follow-Up and Patient Hand-Off</article-title><source>Fed Pract May</source><year>2021</year><volume>38</volume><issue>Suppl 2</issue><fpage>50</fpage><lpage>s56</lpage><pub-id pub-id-type="doi">10.12788/fp.0126</pub-id><pub-id pub-id-type="pmcid">PMC8223734</pub-id><pub-id pub-id-type="pmid">34177241</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shah</surname><given-names>A</given-names></name><name name-style="western"><surname>Hayes</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Martin</surname><given-names>BC</given-names></name></person-group><article-title>Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use - United States, 2006&#8211;2015. <italic toggle="yes">MMWR Morbidity and mortality weekly report</italic></article-title><source>Mar</source><year>2017</year><volume>17</volume><issue>10</issue><fpage>265</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm6610a1</pub-id><pub-id pub-id-type="pmcid">PMC5657867</pub-id><pub-id pub-id-type="pmid">28301454</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><mixed-citation publication-type="other">Hadlandsmyth K, Lund BC, Mosher HJ. Associations between initial opioid exposure and the likelihood for long-term use. <italic toggle="yes">J Am Pharm Assoc (</italic>2003<italic toggle="yes">)</italic>. Jan-Feb 2019;59(1):17&#8211;22. 10.1016/j.japh.2018.09.005.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.japh.2018.09.005</pub-id><pub-id pub-id-type="pmid">30409501</pub-id></mixed-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shah</surname><given-names>A</given-names></name><name name-style="western"><surname>Hayes</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Martin</surname><given-names>BC</given-names></name></person-group><article-title>Factors Influencing Long-Term Opioid Use Among Opioid Naive Patients: An Examination of Initial Prescription Characteristics and Pain Etiologies</article-title><source>J Pain Nov</source><year>2017</year><volume>18</volume><issue>11</issue><fpage>1374</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.jpain.2017.06.010</pub-id><pub-id pub-id-type="pmcid">PMC5660650</pub-id><pub-id pub-id-type="pmid">28711636</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="other">Dowell D, Haegerich TM, Chou R, CDC Guideline for Prescribing Opioids for Chronic Pain - United States., 2016. <italic toggle="yes">MMWR Recomm Rep</italic>. Mar 18 2016;65(1):1&#8211;49. 10.15585/mmwr.rr6501e1.<pub-id pub-id-type="doi" assigning-authority="pmc">10.15585/mmwr.rr6501e1</pub-id><pub-id pub-id-type="pmid">26987082</pub-id></mixed-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Calcaterra</surname><given-names>SLS</given-names></name></person-group><article-title>Prediction of Future Chronic Opioid Use Among Hospitalized Patients</article-title><source>J Gen Intern Med</source><year>2018</year><volume>33</volume><issue>6</issue><fpage>898</fpage><lpage>905</lpage><pub-id pub-id-type="doi">10.1007/s11606-018-4335-8</pub-id><pub-id pub-id-type="pmid">29404943</pub-id><pub-id pub-id-type="pmcid">PMC5975151</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><mixed-citation publication-type="other">Dasgupta N, Funk MJ, Proescholdbell S, Hirsch A, Ribisl KM, Marshall S. Cohort Study of the Impact of High-Dose Opioid Analgesics on Overdose Mortality. <italic toggle="yes">Pain medicine (Malden, Mass)</italic>. Jan 2016;17(1):85&#8211;98. 10.1111/pme.12907.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/pme.12907</pub-id><pub-id pub-id-type="pmid">26333030</pub-id></mixed-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paulozzi</surname><given-names>LJ</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>K</given-names></name><name name-style="western"><surname>Jones</surname><given-names>CM</given-names></name><name name-style="western"><surname>Mack</surname><given-names>KA</given-names></name></person-group><article-title>Risk of adverse health outcomes with increasing duration and regularity of opioid therapy</article-title><source>J Am Board Family Medicine: JABFM May-Jun</source><year>2014</year><volume>27</volume><issue>3</issue><fpage>329</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.3122/jabfm.2014.03.130290</pub-id><pub-id pub-id-type="pmcid">PMC6660001</pub-id><pub-id pub-id-type="pmid">24808111</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paice</surname><given-names>JA</given-names></name></person-group><article-title>Managing Pain in Patients and Survivors: Challenges Within the United States Opioid Crisis</article-title><source>J Natl Compr Cancer Network: JNCCN May</source><year>2019</year><volume>1</volume><issue>55</issue><fpage>595</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.6004/jnccn.2019.5010</pub-id><pub-id pub-id-type="pmid">31117028</pub-id></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Berry</surname><given-names>SD</given-names></name><name name-style="western"><surname>Ngo</surname><given-names>L</given-names></name><name name-style="western"><surname>Samelson</surname><given-names>EJ</given-names></name><name name-style="western"><surname>Kiel</surname><given-names>DP</given-names></name></person-group><article-title>Competing risk of death: an important consideration in studies of older adults</article-title><source>J Am Geriatr Soc Apr</source><year>2010</year><volume>58</volume><issue>4</issue><fpage>783</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1111/j.1532-5415.2010.02767.x</pub-id><pub-id pub-id-type="pmcid">PMC2873048</pub-id><pub-id pub-id-type="pmid">20345862</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>